Results per Page:
Dr. Anat Zimmer receives AAUW fellowship
Fred Hutch computational biologist who relocated from Israel will receive support while investigating cancer genomics
New open source software empowers scientists to uncover immune secrets
'Infinity Flow’ adds machine learning to widespread, but limited, technology for analyzing single cells
Forecasting the shape of flu viruses to come
‘Deep mutational scanning’ to make a better flu vaccine
Machine learning provides new insights into tumor suppression
Algorithm illuminated surprising metabolic effects of important cancer gene
Good News: Fred Hutch immunotherapy expert Dr. Phil Greenberg joins Parker Institute
Celebrating faculty and staff achievements
Good News: Mary Potts, Fred Hutch's Cancer Surveillance System guru, wins award for distinguished service
Celebrating faculty and staff achievements
New library of HIV mutants could inform vaccine design
Laboratory manipulation of the AIDS-causing virus reveals evolutionary ‘dead-ends’
Good News: Drs. Grzelak, Anderson get Komen awards; Infectious Disease Sciences earns training grant; Drs. Bloom, Matsen named HHMI-Simons Faculty Scholars
Celebrating faculty and staff achievements
Immunotherapy-simplifying nanoparticle research gets boost from National Science Foundation
Celebrating faculty and staff achievements
Good News at Fred Hutch: Dr. Anne McTiernan named to HHS panel; Dr. Harlan Robins is co-PI on two projects
Celebrating faculty and staff achievements
Drs. Michael Emerman and Nina Salama elected to Fellowship in the American Academy of Microbiology
Celebrating faculty and staff achievements
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements
Reaching for answers
Researchers’ friends and family see scientists as conduits for hope
Building a better protein in the hope of better therapies
Researchers design and create donut-shaped proteins from scratch
Study sheds new light on molecular pathways behind marrow disorders
How a single alteration in fundamental cellular machinery drives blood diseases and cancers
High-throughput sequencing outpaces flow cytometry for earliest detection of cancer relapse
Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method